Inhibition of FGFR/PDGFR /VEGFR signaling reduces pancreatic cancer growth by direct effects on tumor cells, endothelial cells and pericytes

被引：0
|
作者：
Lang, Sven
Taeger, Johannes
Moser, Christian
Hack, Christina
Schlitt, Hans
Geissler, Edward
Stoeltzing, Oliver
机构：
[1] Univ Regensburg, Dept Surg, D-93053 Regensburg, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Surg, D-55122 Mainz, Germany
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5578
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer
    Taeger, Johannes
    Moser, Christian
    Hellerbrand, Claus
    Mycielska, Maria E.
    Glockzin, Gabriel
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    Lang, Sven A.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2157 - 2167
  • [2] Dual-inhibition of Raf kinase and VEGFR2 reduces pancreatic cancer growth through direct effects on tumor cells and endothelial cells
    Lang, S. A.
    Moser, C.
    Schachtschneider, P.
    Schlitt, H. J.
    Geissler, E. K.
    Stoeltzing, O.
    ONKOLOGIE, 2008, 31 : 154 - 155
  • [3] Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
    Lang, Sven A.
    Schachtschneider, Philipp
    Moser, Christian
    Mori, Akira
    Hackl, Christina
    Gaumann, Andreas
    Batt, David
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3509 - 3518
  • [4] The effects of inhibition of PDGFR-β in retinal endothelial cells within the retinoblastoma tumor microenvironment
    Goldsmith, Zachary K.
    Coppess, William
    Yuan, Kelley
    Irvine, Andrew S.
    Brennan, Rachel
    Wilson, Matthew W.
    Morales, Vanessa Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [5] Blockade of the fibroblast growth factor receptor (FGFR) system by the novel FGFR inhibitor BGJ398 modulates oncogenic signaling in human gastric cancer cells, endothelial cells and pericytes
    Moser, Christian
    Hackl, Christina
    Schlitt, Hans J.
    Geissler, Edward K.
    Lang, Sven A.
    CANCER RESEARCH, 2012, 72
  • [6] Dovitinib (TKI258), a multikinase inhibitor of FGFR, PDGFR, and VEGFR tyrosine kinases, induces growth inhibition in endometrial carcinoma cells
    Konecny, Gottfried E.
    Winterhoff, Boris
    Guorong, Ellen Yang
    Qi, Jingwei
    Le, Julie
    Shi, Michael
    Dugan, Margaret
    Linnartz, Ronald
    Finn, Richard S.
    Slamon, Dennis J.
    CANCER RESEARCH, 2011, 71
  • [7] PGF-VEGFR1 signaling mediates the crosstalk of retinal endothelial cells and pericytes in diabetic retinopathy
    Huang, Hu
    Liu, Ying
    Lennikov, Anton
    Fan, Lijuan
    Xu, Heping
    Chen, Jiansu
    Tang, Shibo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models
    Crawford, Kate
    Bontrager, Erin
    Schwarz, Margaret A.
    Chaturvedi, Apurva
    Lee, Daniel D.
    Md Sazzad, Hassan
    von Holzen, Urs
    Zhang, Changhua
    Schwarz, Roderich E.
    Awasthi, Niranjan
    CANCER BIOLOGY & THERAPY, 2021, 22 (10-12) : 619 - 629
  • [9] Unraveling the importance of pancreatic cancer extracellular signaling to endothelial cells within the tumor microenvironment
    Finan, Jennifer M.
    Guo, Yifei
    MacPherson, Kevin
    Calvert, Valerie
    Pelz, Carl
    Petricoin, Emanuel F.
    Saugstad, Julie A.
    Sears, Rosalie
    Brody, Jonathan R.
    CANCER RESEARCH, 2024, 84 (02)
  • [10] Unraveling the importance of pancreatic cancer extracellular signaling to endothelial cells within the tumor microenvironment
    Finan, Jennifer M.
    Guo, Yifei
    Bartlett, Alexandra Q.
    MacPherson, Kevin
    Calvert, Valerie
    Hedberg, Madeline D.
    Petricoin, Emanuel
    Sears, Rosalie
    Brody, Jonathan R.
    CANCER RESEARCH, 2024, 84 (06)
12345